October 01, 2014 6:07 PM ET

Company Overview of Popper and Co.

Company Overview

,  

United States

Key Executives for Popper and Co.

Co-Founder and President
Co-Founder
Head of Digital Health Strategy
Strategic Advisor
Compensation as of Fiscal Year 2014.

Popper and Co. Key Developments

Popper and Company Announces Appointment of Senior Advisors

Popper and Company announced that it has added three industry veterans as senior advisors. Michael C. Little, Ph.D., who recently retired from his role as VP/Global Head Diagnostics Development, Companion Diagnostics Unit, Novartis Oncology; David L. Scher, M.D., pioneer adopter of remote patient monitoring and thought leader on the topic of digital health technology; and Niall Sweeney, an innovator of drug delivery, medical information, orthopedics and dentistry products, have joined the Popper and Company team. Each of these professionals brings deep operational business experience and further strengthens the capabilities that Popper and Company offers its clients as they address some of the most complex challenges facing the healthcare industry. Michael Little, Ph.D., joins Popper and Company following a long tenure in senior executive roles in the in vitro diagnostic (IVD) and companion diagnostic (CDx) industries, most recently at Novartis. David Lee Scher, M.D., is a cardiac electrophysiologist, and a pioneer adopter of remote patient monitoring and integration of monitored devices with electronic health records. Niall Sweeney has repeatedly grown businesses by delivering innovative medical products in markets such as drug delivery, medical information, orthopedics and dentistry.

Popper and Company Announces Stephanie Kreml, M.D., as Newest Team Member

Popper and Company announced that Stephanie Kreml, M.D. has returned to the firm as Principal. Dr. Kreml, who previously worked at Popper and Company from 2008 to 2010, has a broad career spanning clinical research, product engineering, medical technologies, and commercialization strategy roles. In her role as Principal, Dr. Kreml will develop and implement business strategy for start-up companies and new business units in existing companies; consult in areas of clinical need, commercialization, and technology assessment; perform due diligence for investment and acquisition targets in the life science industry; critically evaluate unmet clinical needs and technologies; and provide guidance to accelerate new production development activities. From 2010 to 2013, Dr. Kreml held the positions of Associate Medical Director and Center Medical Director at Concentra in Austin, Texas, and she continues to practice as a staff physician part-time. Prior to medical school, she held engineering positions with Motorola and Texas Instruments.

Popper and Co. Presents at The 14th Annual Southeast BIO (SEBIO) Investor Forum, Oct-31-2012 01:30 PM

Popper and Co. Presents at The 14th Annual Southeast BIO (SEBIO) Investor Forum, Oct-31-2012 01:30 PM. Venue: The Breakers Resort, Palm Beach, Florida, United States. Speakers: Caroline Popper, Co-Founder and President.

Similar Private Companies By Industry

Company Name Region
Baird Equity Capital Markets United States
Brian Michael Mark, PA United States
Round Lake Area Park District United States
TBI Development, LLC United States
TSC Group, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Popper and Co., please visit www.popperandco.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.